Ease: Empagliflozin Beneficial In Type 1 Diabetes Dka A Risk | Latest News RSS feed

Ease: Empagliflozin Beneficial In Type 1 Diabetes Dka A Risk - Latest News


Boehringer Ingelheim and Lilly present full results from EASE Phase III programme for empagliflozin as adjunct to insulin in type 1 diabetes

The EASE programme results were published online ... Canada. “Given the risk of DKA for people with type 1 diabetes, the 2.5 mg empagliflozin dose warrants consideration, as it balances glycaemic and ... read more

US FDA approves sNDA to add trial data in labels of three type 2 diabetes drugs within empagliflozin family

The data show that empagliflozin ... for the treatment of type 1 diabetes or diabetic ketoacidosis. Glyxambi has not been studied in patients with a history of pancreatitis, and it is unknown if using ... read more

Lexicon Likely Looking At Even More Competition In Type 1 Diabetes

Lexicon could really use some good news, as the company ... s somewhat cryptic release regarding its EASE-2 and EASE-3 trials of Jardiance in Type 1 diabetes back in the summer created some hope that ... read more

Looking for another news?


John Buse 2018 Transcript

Not a cure, but really good ... about type 1s and the SGLT-2s? Buse: So, there are a huge number of presentations here at the ADA on the use of SGLT-2 Inhibitors in type 1 diabetes and the main issue ... read more


Boehringer Ingelheim and Lilly announce positive top-line Phase III data results for empagliflozin as adjunct to insulin in type 1 diabetes

The number of adjudicated diabetic ketoacidosis events was comparable between empagliflozin 2.5 mg and placebo and higher than placebo in adults with type 1 diabetes on empagliflozin 10 mg and 25 mg. ... read more

NDSU researchers aiming for diabetes monitoring without a poke

But he said it could be useful for a patient to know if they should be seen immediately, for example, if they’ve developed a condition such as diabetic ketoacidosis ... monitoring air or water polluti... read more

The Danger of Diabetic Ketoacidosis

DKA can quickly become a medical emergency. Fortunately, DKA responds to prompt treatment. DKA is preventable. Keeping blood sugar under control is the challenge. For people with Type 1 ... diabetes, ... read more

Timely News and Notes for Primary Care Providers From The American Diabetes Association

One piece of good ... Benefits in Type 1 Diabetes The sodium–glucose cotransporter 2 (SGLT2) inhibitor empagliflozin can improve glycemic control and reduce weight in patients with type 1 diabetes, bu... read more

FDA adcomm split on Sanofi’s type 1 diabetes drug

The FDA convened an advisory committee meeting to help ... the risk of diabetic ketoacidosis (DKA), a side effect that in severe cases can lead to kidney damage, respiratory failure and death. Lexicon ... read more

Boehringer Ingelheim and Lilly present full results from EASE Phase III program for empagliflozin as adjunct to insulin in type 1 diabetes

Apart from incidence of DKA, the safety profile observed in the EASE ... The benefit-risk profile of empagliflozin has been well-established in its approved indications. Empagliflozin is currently not ... read more

A Weak Xermelo Ramp Continues To Weigh On Lexicon

If Neurocrine’s (NBIX) launch of Ingrezza in tardive dyskinesia is a good example of an ... non-insulin therapy option for Type 1 diabetes. Data also continue to show that these drugs do increase the ... read more

New analysis estimates the positive impact of Jardiance® on life expectancy in adults with type 2 diabetes and established cardiovascular disease

... is also used to reduce the risk of cardiovascular death in adults with type 2 diabetes who have known cardiovascular disease. JARDIANCE is not for people with type 1 diabetes or for people with di... read more



FeedsRSS Created by. Full RSS Feed | Privacy Policy | Contact Us